WHO releases rapid communication on controlled medicines guideline

The World Health Organization (WHO) has issued a rapid communication on its forthcoming guideline on controlled medicines, designed to support national policies that strike a balance between access and safety.

PAREA was honoured to be invited to join the External Review Group for this new guideline. Our contribution was developed with a multidisciplinary focus group of legal, clinical, and research experts, and underscored the importance of ensuring access to controlled substances for scientific research and for addressing serious unmet medical needs.
Our participation in this process reflects a growing global recognition of the medical potential of psychedelics and the need to support the development of these treatments.

Read the communication here.